8-KRegulation FDExhibits & Filings

STARBUCKS CORP 8-K Report, Regulation FD Disclosure (Mar 5, 2020)

Filed March 5, 2020For Securities:SBUX

Summary

Starbucks Corporation (SBUX) filed an 8-K on March 5, 2020, to provide an update on the estimated financial impact of the coronavirus (COVID-19) outbreak on its second fiscal quarter of 2020 (Q2 FY20) performance. The primary focus of this filing is to disclose the disruptions in China, which is a significant market for Starbucks, and how these disruptions are expected to affect the company's financial results. Investors should pay close attention to the quantitative estimates provided regarding the impact on sales and earnings due to this unprecedented event. The company is using this filing to proactively communicate potential headwinds stemming from the COVID-19 outbreak, specifically highlighting the temporary business disruptions in China. While the full extent of the impact would be clearer in subsequent earnings reports, this 8-K serves as an early warning and provides initial guidance on the financial consequences. Investors are advised to review the attached exhibit for detailed estimates and further context provided by Starbucks management.

Key Highlights

  • 1Starbucks filed an 8-K on March 5, 2020, to discuss the impact of COVID-19.
  • 2The filing specifically addresses the estimated financial impact on Q2 FY20 results.
  • 3The primary driver of the impact discussed is the temporary business disruption in China.
  • 4This report serves as a Regulation FD disclosure to inform investors.
  • 5Exhibit 99.1 contains detailed estimates of the financial impact.
  • 6The company is providing early insights into potential headwinds due to the coronavirus outbreak.

Frequently Asked Questions

The main purpose of this 8-K filing is to inform investors about the estimated financial impact of the COVID-19 outbreak, specifically the temporary business disruptions in China, on Starbucks' second fiscal quarter of 2020 (Q2 FY20) results.

The specific event causing the financial impact is the outbreak of coronavirus disease (COVID-19) and the resulting temporary business disruptions experienced in China.

The detailed financial impact estimates are provided in Exhibit 99.1, which is attached to this 8-K filing.

This filing is an update on the estimated impact of the COVID-19 situation on Q2 FY20 results. For specific quantitative estimates such as EPS or revenue figures, investors should refer to the details provided in Exhibit 99.1 or await subsequent official earnings releases.